Ordinary Adjustment | Solactive China Biotech Index Family | Effective 11. July 2022
Solactive China Biotech Index:
In the ordinary rebalancing the following index composition was implemented:
APELOA PHARMACEUTICAL CO-A | 1.8461 % |
BEIJING TIANTAN BIOLOGICAL-A | 2.3178 % |
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7227 % |
BETTA PHARMACEUTICALS CO L-A | 1.9841 % |
BGI GENOMICS CO LTD-A | 2.353 % |
CANSINO BIOLOGICS INC | 0.6963 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1119 % |
DAAN GENE CO LTD-A | 2.483 % |
GAN & LEE PHARMACEUTICALS -A | 1.1977 % |
GENSCRIPT BIOTECH CORP | 4.4339 % |
HANSOH PHARMACEUTICAL GROUP CO | 2.2551 % |
HUALAN BIOLOGICAL ENGINEER-A | 2.8982 % |
HUBEI JUMPCAN PHARMACEUT-A | 1.3601 % |
HUTCHISON CHINA MEDITECH-ADR | 2.3485 % |
Hygeia Healthcare Holdings Co Ltd | 2.2211 % |
INNOVENT BIOLOGICS INC | 6.7076 % |
JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
LIVZON PHARMACEUTICAL GROU-A | 2.0098 % |
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.6081 % |
REMEGEN CO LTD-H | 0.6737 % |
SHANGHAI JUNSHI BIOSCIENCE | 4.1255 % |
SHANGHAI RAAS BLOOD PRODUC-A | 2.2476 % |
SHENZHEN KANGTAI BIOLOGICA-A | 2.9013 % |
SIMCERE PHARMACEUTICAL GROUP | 0.6734 % |
SINO BIOPHARMACEUTICAL LTD ORD | 6.3309 % |
WALVAX BIOTECHNOLOGY CO-A | 9.0 % |
WUXI APPTEC CO LTD-A | 9.0 % |
WUXI BIOLOGICS CAYMAN INC | 9.0 % |
ZAI LAB LTD | 3.5369 % |
ZHEJIANG WOLWO BIO-PHARMAC-A | 1.9558 % |
Solactive China Biotech v2 Index:
In the ordinary rebalancing the following index composition was implemented:
APELOA PHARMACEUTICAL CO-A | 1.8461 % |
BEIJING TIANTAN BIOLOGICAL-A | 2.3178 % |
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7227 % |
BETTA PHARMACEUTICALS CO L-A | 1.9841 % |
BGI GENOMICS CO LTD-A | 2.353 % |
CANSINO BIOLOGICS INC | 0.6963 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1119 % |
DAAN GENE CO LTD-A | 2.483 % |
GAN & LEE PHARMACEUTICALS -A | 1.1977 % |
GENSCRIPT BIOTECH CORP | 4.4339 % |
HANSOH PHARMACEUTICAL GROUP CO | 2.2551 % |
HUALAN BIOLOGICAL ENGINEER-A | 2.8982 % |
HUBEI JUMPCAN PHARMACEUT-A | 1.3601 % |
HUTCHISON CHINA MEDITECH-ADR | 2.3485 % |
Hygeia Healthcare Holdings Co Ltd | 2.2211 % |
INNOVENT BIOLOGICS INC | 6.7076 % |
JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
LIVZON PHARMACEUTICAL GROU-A | 2.0098 % |
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.6081 % |
REMEGEN CO LTD-H | 0.6737 % |
SHANGHAI JUNSHI BIOSCIENCE | 4.1255 % |
SHANGHAI RAAS BLOOD PRODUC-A | 2.2476 % |
SHENZHEN KANGTAI BIOLOGICA-A | 2.9013 % |
SIMCERE PHARMACEUTICAL GROUP | 0.6734 % |
SINO BIOPHARMACEUTICAL LTD ORD | 6.3309 % |
WALVAX BIOTECHNOLOGY CO-A | 9.0 % |
WUXI APPTEC CO LTD-A | 9.0 % |
WUXI BIOLOGICS CAYMAN INC | 9.0 % |
ZAI LAB LTD | 3.5369 % |
ZHEJIANG WOLWO BIO-PHARMAC-A | 1.9558 % |